Keywords

• (1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopent
• supply Peramivir
• Peramivir 99%

Quick Details

• ProName: Peramivir
• CasNo: 330600-85-6
• Molecular Formula: C15H28N4O4
• Appearance: white powder
• Application: API
• DeliveryTime: delivery after confirming an order
• PackAge: aluminium foil bag; drum; as per your ...
• ProductionCapacity: Metric Ton/Day
• Purity: 99%
• Storage: store in cool place. Keep container ti...
• Transportation: air transport, sea transport
• LimitNum: 1 Gram

Superiority

Details

 Trading information  

Sample Service

Considering the various needs of buyers, we provide small quantity sample to customers. You are welcomed to contact us for the detailed specifications of our APIs and pharmaceutical intermediates. Customers are also expected to confirm the type of freight transport and  payment. Any more question please contact us directly.

Application as Antiviral Agent

In October 2009, it was reported that the experimental antiviral drug peramivir had been effective in treating serious cases of swine flu. On October 23, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization for Peramivir, allowing the use of the drug in intravenous form for hospitalized patients only in cases where the other available methods of treatment are ineffective or unavailable; for instance, if oseltamivir (Tamiflu) resistance develops and a person is unable to take Relenza via the inhaled route. The Emergency Use Authorization expired on June 23, 2010.

Biocryst also donated 1200 courses of treatment to the US department of Health and Human Services.

According to a research report published in June 2011, a novel variant of swine flu has emerged in Asia with a genetic adaptation giving some resistance to Roche's (ROG.VX) Tamiflu and GlaxoSmithKline's (GSK.L) Relenza, the two mainstay drugs used to tackle the disease. There was no significant reduction in sensitivity to Peramivir.

Research and Development

Relying on advanced research platform and relative service of China Medicine City, Allyrise have made achievements in areas of antineoplastic, antiviral, diabetes drugs in recent years, with more than 20 kinds of APIs and advanced intermediates magnified in pilotscale experiment. The products are widely sold to famous pharmaceutical companies from around the world. To enhance our research and development level, Allyrise developed close cooperation with foreign pharmaceutical companies in customer synthesis and developing new drugs.

Technical Team

Jiangsu Allyrise Pharmaceutical Co., Ltd have a young and innovative technician team with average age of 29 and backgrounds of famous universerties. We have rich experience in lab research and pilot scale experiment, laying the foundation for further personnel cultivation.

Escrow Service

 Allyrise accept Escrow Service which is based on Lookchem as a third-party. Both buyer and seller are guranteed that their transaction is simple and secure.